Plasma Exosomes of Patients with Breast and Ovarian Tumors Contain an Inactive 20S Proteasome

Exosomes are directly involved in governing of physiological and pathological conditions of an organism through the transfer of information from producing to receiving cells. It can be assumed that exosomes are one of the key players of tumor dissemination since they are very stable and small enough...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Natalia Yunusova, Elena Kolegova, Elena Sereda, Larisa Kolomiets, Alisa Villert, Marina Patysheva, Irina Rekeda, Alina Grigor’eva, Natalia Tarabanovskaya, Irina Kondakova, Svetlana Tamkovich
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/9fb909344d21442580cb693cf38debf2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9fb909344d21442580cb693cf38debf2
record_format dspace
spelling oai:doaj.org-article:9fb909344d21442580cb693cf38debf22021-11-25T18:28:47ZPlasma Exosomes of Patients with Breast and Ovarian Tumors Contain an Inactive 20S Proteasome10.3390/molecules262269651420-3049https://doaj.org/article/9fb909344d21442580cb693cf38debf22021-11-01T00:00:00Zhttps://www.mdpi.com/1420-3049/26/22/6965https://doaj.org/toc/1420-3049Exosomes are directly involved in governing of physiological and pathological conditions of an organism through the transfer of information from producing to receiving cells. It can be assumed that exosomes are one of the key players of tumor dissemination since they are very stable and small enough to penetrate from various tissues into biological fluids and then back, thus interacting with tissue target cells. We evaluated the enzymatic activity and the level of 20S proteasome in tissue and exosomes of healthy females (<i>n</i> = 39) and patients with ovarian (<i>n</i> = 50) and breast (<i>n</i> = 108) tumors to reveal the critical role of exosomal cargo in the mediation of different types of metastases. Exosomes from plasma and ascites were isolated and characterized in according to International Society for Extracellular Vesicles guidelines. The level of 20S proteasome in tissue and exosomes was determined using Western blot analysis. Chymotrypsin- and caspase-like (ChTL and CL, respectively) peptidase activities of the proteasomes were determined using fluorogenic Suc-LLVY-AMC and Cbz-LLG-AMC substrates, respectively. We observed increased levels of 20S proteasome in ovarian cancer tissue and luminal B subtype breast cancer tissue as well as in plasma exosomes from cancer patients. Moreover, the level of the 20S proteasome in plasma exosomes and ascites exosomes in patients with ovarian tumors is comparable and higher in ovarian cancer patients with low volume ascites than in patients with moderate and high-volume ascites. We also found increased ChTL and CL activities in breast cancer and ovarian cancer tissues, as well as in peritoneal metastases in ovarian cancer, while proteasomal activity in exosomes from plasma of healthy females and all patients, as well as from ascites of ovarian tumor patients were lower than detection limit of assay. Thus, regardless of the type of tumor metastasis (lymphogenous or peritoneal), the exosomes of cancer patients were characterized by an increased level of 20S proteasome, which do not exhibit enzymatic activity.Natalia YunusovaElena KolegovaElena SeredaLarisa KolomietsAlisa VillertMarina PatyshevaIrina RekedaAlina Grigor’evaNatalia TarabanovskayaIrina KondakovaSvetlana TamkovichMDPI AGarticleexosomes20S proteasomeplasmatissuebreast cancerovarian cancerOrganic chemistryQD241-441ENMolecules, Vol 26, Iss 6965, p 6965 (2021)
institution DOAJ
collection DOAJ
language EN
topic exosomes
20S proteasome
plasma
tissue
breast cancer
ovarian cancer
Organic chemistry
QD241-441
spellingShingle exosomes
20S proteasome
plasma
tissue
breast cancer
ovarian cancer
Organic chemistry
QD241-441
Natalia Yunusova
Elena Kolegova
Elena Sereda
Larisa Kolomiets
Alisa Villert
Marina Patysheva
Irina Rekeda
Alina Grigor’eva
Natalia Tarabanovskaya
Irina Kondakova
Svetlana Tamkovich
Plasma Exosomes of Patients with Breast and Ovarian Tumors Contain an Inactive 20S Proteasome
description Exosomes are directly involved in governing of physiological and pathological conditions of an organism through the transfer of information from producing to receiving cells. It can be assumed that exosomes are one of the key players of tumor dissemination since they are very stable and small enough to penetrate from various tissues into biological fluids and then back, thus interacting with tissue target cells. We evaluated the enzymatic activity and the level of 20S proteasome in tissue and exosomes of healthy females (<i>n</i> = 39) and patients with ovarian (<i>n</i> = 50) and breast (<i>n</i> = 108) tumors to reveal the critical role of exosomal cargo in the mediation of different types of metastases. Exosomes from plasma and ascites were isolated and characterized in according to International Society for Extracellular Vesicles guidelines. The level of 20S proteasome in tissue and exosomes was determined using Western blot analysis. Chymotrypsin- and caspase-like (ChTL and CL, respectively) peptidase activities of the proteasomes were determined using fluorogenic Suc-LLVY-AMC and Cbz-LLG-AMC substrates, respectively. We observed increased levels of 20S proteasome in ovarian cancer tissue and luminal B subtype breast cancer tissue as well as in plasma exosomes from cancer patients. Moreover, the level of the 20S proteasome in plasma exosomes and ascites exosomes in patients with ovarian tumors is comparable and higher in ovarian cancer patients with low volume ascites than in patients with moderate and high-volume ascites. We also found increased ChTL and CL activities in breast cancer and ovarian cancer tissues, as well as in peritoneal metastases in ovarian cancer, while proteasomal activity in exosomes from plasma of healthy females and all patients, as well as from ascites of ovarian tumor patients were lower than detection limit of assay. Thus, regardless of the type of tumor metastasis (lymphogenous or peritoneal), the exosomes of cancer patients were characterized by an increased level of 20S proteasome, which do not exhibit enzymatic activity.
format article
author Natalia Yunusova
Elena Kolegova
Elena Sereda
Larisa Kolomiets
Alisa Villert
Marina Patysheva
Irina Rekeda
Alina Grigor’eva
Natalia Tarabanovskaya
Irina Kondakova
Svetlana Tamkovich
author_facet Natalia Yunusova
Elena Kolegova
Elena Sereda
Larisa Kolomiets
Alisa Villert
Marina Patysheva
Irina Rekeda
Alina Grigor’eva
Natalia Tarabanovskaya
Irina Kondakova
Svetlana Tamkovich
author_sort Natalia Yunusova
title Plasma Exosomes of Patients with Breast and Ovarian Tumors Contain an Inactive 20S Proteasome
title_short Plasma Exosomes of Patients with Breast and Ovarian Tumors Contain an Inactive 20S Proteasome
title_full Plasma Exosomes of Patients with Breast and Ovarian Tumors Contain an Inactive 20S Proteasome
title_fullStr Plasma Exosomes of Patients with Breast and Ovarian Tumors Contain an Inactive 20S Proteasome
title_full_unstemmed Plasma Exosomes of Patients with Breast and Ovarian Tumors Contain an Inactive 20S Proteasome
title_sort plasma exosomes of patients with breast and ovarian tumors contain an inactive 20s proteasome
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/9fb909344d21442580cb693cf38debf2
work_keys_str_mv AT nataliayunusova plasmaexosomesofpatientswithbreastandovariantumorscontainaninactive20sproteasome
AT elenakolegova plasmaexosomesofpatientswithbreastandovariantumorscontainaninactive20sproteasome
AT elenasereda plasmaexosomesofpatientswithbreastandovariantumorscontainaninactive20sproteasome
AT larisakolomiets plasmaexosomesofpatientswithbreastandovariantumorscontainaninactive20sproteasome
AT alisavillert plasmaexosomesofpatientswithbreastandovariantumorscontainaninactive20sproteasome
AT marinapatysheva plasmaexosomesofpatientswithbreastandovariantumorscontainaninactive20sproteasome
AT irinarekeda plasmaexosomesofpatientswithbreastandovariantumorscontainaninactive20sproteasome
AT alinagrigoreva plasmaexosomesofpatientswithbreastandovariantumorscontainaninactive20sproteasome
AT nataliatarabanovskaya plasmaexosomesofpatientswithbreastandovariantumorscontainaninactive20sproteasome
AT irinakondakova plasmaexosomesofpatientswithbreastandovariantumorscontainaninactive20sproteasome
AT svetlanatamkovich plasmaexosomesofpatientswithbreastandovariantumorscontainaninactive20sproteasome
_version_ 1718411095371153408